Cargando…
Testosterone therapy reduces hepatic steatosis in men with type 2 diabetes and low serum testosterone concentrations
BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is highly prevalent in people with diabetes with no available treatment. AIM: To explore the effect of testosterone treatment on liver. Testosterone therapy improves insulin resistance and reduces total body fat, but its impact on the liver remai...
Autores principales: | Apostolov, Ross, Gianatti, Emily, Wong, Darren, Kutaiba, Numan, Gow, Paul, Grossmann, Mathis, Sinclair, Marie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099110/ https://www.ncbi.nlm.nih.gov/pubmed/35646271 http://dx.doi.org/10.4254/wjh.v14.i4.754 |
Ejemplares similares
-
Hepatocellular carcinoma surveillance and quantile regression for determinants of underutilisation in at-risk Australian patients
por: Low, Elizabeth SL, et al.
Publicado: (2021) -
Approach to the Patient: The Evaluation and Management of Men ≥50 Years With Low Serum Testosterone Concentration
por: Grossmann, Mathis, et al.
Publicado: (2023) -
Obesity, type 2 diabetes, and testosterone in ageing men
por: Wittert, Gary, et al.
Publicado: (2022) -
Genetic Determinants of Serum Testosterone Concentrations in Men
por: Ohlsson, Claes, et al.
Publicado: (2011) -
Histologically proven hepatic steatosis associates with lower testosterone levels in men with obesity
por: Van de Velde, Frederique, et al.
Publicado: (2019)